TY - JOUR
T1 - Regression from prediabetes to normal glucose levels is more frequent than progression towards diabetes
T2 - The CRONICAS Cohort Study
AU - Lazo-Porras, Maria
AU - Bernabe-Ortiz, Antonio
AU - Ruiz-Alejos, Andrea
AU - Smeeth, Liam
AU - Gilman, Robert H.
AU - Checkley, William
AU - Málaga, German
AU - Miranda, J. Jaime
N1 - Publisher Copyright:
© 2019 Elsevier B.V.
PY - 2020/5
Y1 - 2020/5
N2 - Aims: This study aimed to (1) estimate the prevalence of prediabetes according to different definitions, (2) evaluate regression to normal glucose levels and progression towards T2DM, and (3) determine factors associated with regression and progression across four diverse geographical settings in a Latin American country. Methods: The CRONICAS Cohort Study was conducted in four different areas in Peru. Enrollment started in September 2010 and follow-up was conducted in 2013. Prediabetes, T2DM and normal glucose levels were determined according to definitions from the World Health Organization (WHO), American Diabetes Association (ADA), and National Institute for Health and Care Excellence (NICE). The main outcomes were regression to normal glucose levels and incidence of T2DM. Prevalence estimates and 95% confidence intervals (95% CI) were calculated. Crude and adjusted models using Poisson regression were performed and relative risk ratios (RRR) and 95% CI were calculated. Results: At baseline, the prevalence of prediabetes varied markedly by definition used: 6.5%(95% CI 5.6−7.6%), 53.6% (95% CI 51.6−55.6%), and 24.6% (95% CI 22.8−26.4%) according to WHO, ADA and NICE criteria, respectively. After 2.2 years of follow-up, in those with prediabetes, the cumulative incidence of regression to euglycemia ranged between 31.4% and 68.9%, whereas the incidence of T2DM varied from 5.5% to 28.8%. Factors associated with regression to normal glucose levels and progression to diabetes were age, body mass index, and insulin resistance. Conclusions: Regression from pre-diabetes back to euglycemia was much more common than progression to diabetes.
AB - Aims: This study aimed to (1) estimate the prevalence of prediabetes according to different definitions, (2) evaluate regression to normal glucose levels and progression towards T2DM, and (3) determine factors associated with regression and progression across four diverse geographical settings in a Latin American country. Methods: The CRONICAS Cohort Study was conducted in four different areas in Peru. Enrollment started in September 2010 and follow-up was conducted in 2013. Prediabetes, T2DM and normal glucose levels were determined according to definitions from the World Health Organization (WHO), American Diabetes Association (ADA), and National Institute for Health and Care Excellence (NICE). The main outcomes were regression to normal glucose levels and incidence of T2DM. Prevalence estimates and 95% confidence intervals (95% CI) were calculated. Crude and adjusted models using Poisson regression were performed and relative risk ratios (RRR) and 95% CI were calculated. Results: At baseline, the prevalence of prediabetes varied markedly by definition used: 6.5%(95% CI 5.6−7.6%), 53.6% (95% CI 51.6−55.6%), and 24.6% (95% CI 22.8−26.4%) according to WHO, ADA and NICE criteria, respectively. After 2.2 years of follow-up, in those with prediabetes, the cumulative incidence of regression to euglycemia ranged between 31.4% and 68.9%, whereas the incidence of T2DM varied from 5.5% to 28.8%. Factors associated with regression to normal glucose levels and progression to diabetes were age, body mass index, and insulin resistance. Conclusions: Regression from pre-diabetes back to euglycemia was much more common than progression to diabetes.
KW - Diabetes
KW - Disease progression
KW - Insulin resistance
KW - Longitudinal studies
KW - Low-and middle-income countries
KW - Normal glucose levels
KW - Peru
KW - Prediabetes
UR - http://www.scopus.com/inward/record.url?scp=85082723705&partnerID=8YFLogxK
U2 - 10.1016/j.diabres.2019.107829
DO - 10.1016/j.diabres.2019.107829
M3 - Artículo
C2 - 31465811
AN - SCOPUS:85082723705
SN - 0168-8227
VL - 163
JO - Diabetes Research and Clinical Practice
JF - Diabetes Research and Clinical Practice
M1 - 107829
ER -